AFINITOR vs EVEROLIMUS
Independent side-by-side comparison.
Rating
70/100
70/100
Pharmacy pays
~$229.16 /30
~$229.16 /30
Type
RX
RX
Active ingredient
EVEROLIMUS
EVEROLIMUS
Manufacturer
Dosage forms
Tablet
Tablet
Drug class
Kinase Inhibitor
Kinase Inhibitor
Boxed warning
None
Half-life
about 30 hours (mean terminal elimination half-life)
about 30 hours (mean terminal elimination half-life)
Frequently asked questions
Which is better-rated, Afinitor or Everolimus?
Afinitor and Everolimus are tied at 3.5 out of 5 by our independent rating.
Which is cheaper, Afinitor or Everolimus?
Pharmacies pay about the same to acquire either one — roughly $229.16 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Afinitor and Everolimus?
Both Afinitor and Everolimus share the active ingredient Everolimus.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.